BNP Paribas Call 130 AP2 17.01.20.../ DE000PE89XV6 /
24/05/2024 8:43:26 | Diferencia- | Bid8:20:03 | Ask8:20:03 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
8.72EUR | - | 8.88 Volumen de oferta: 750 |
- Tamaño/ Volumen/ Formato de Ask: - |
APPLIED MATERIALS IN... | 130.00 - | 17/01/2025 | Call |
GlobeNewswire
7:00
Press Release: Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible ...
GlobeNewswire
6:00
For startups changing the world, an AI company called Bizzline brings the power to tell their own st...
GlobeNewswire
5:21
Flash News: OKX Wallet Announces Near Protocol Integration, Supports Over 95 Blockchains
Newsfile Corp
4:12
InsFollowPro Acquires Statigr.am: A New Chapter in Social Media Analytics and Growth
GlobeNewswire
3:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Spr...
GlobeNewswire
3:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Int...
GlobeNewswire
3:00
CAMBIUM ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Agai...
GlobeNewswire
3:00
VERRICA ALERT: Bragar Eagel & Squire, P.C. is Investigating Verrica Pharmaceuticals, Inc. on Behalf ...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página